This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| ab science | ORG | 1 | π π π§² |
| ab sciences | ORG | 1 | π π π§² |
| ab8939 | PRODUCT | 1 | π π π§² |
| abbvies venclexta | PRODUCT | 1 | π π π§² |
| als | ORG | 1 | π π π§² |
| andrii yalanskyi | PERSON | 1 | π π π§² |
| biospace | ORG | 1 | π π π§² |
| french | NORP | 1 | π π π§² |
| last month | DATE | 1 | π π π§² |
| GPE | 1 | π π π§² | |
| linkedin facebook | PERSON | 1 | π π π§² |
| manalac | PERSON | 1 | π π π§² |
| manalac tristan | PERSON | 1 | π π π§² |
| mcas | ORG | 1 | π π π§² |
| metro manila | GPE | 1 | π π π§² |
| news business ab science | ORG | 1 | π π π§² |
| one | CARDINAL | 1 | π π π§² |
| pipeline tristan | PERSON | 1 | π π π§² |
| roche | ORG | 1 | π π π§² |
| stΓ©phane ledermann | PERSON | 1 | π π π§² |
| tristan | GPE | 1 | π π π§² |
| venclexta | ORG | 1 | π π π§² |
| Domain | Articles | % | Actions |
|---|---|---|---|
|
|
1 | 100.00 | π π° π§² |
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-13 11:32:10+00 | Science |
|
AB Science ends three studies in multiple sclerosis, other immune conditions | Analyze | https://www.biospace.com/tristan-manalac | π neutral | 0.0696 |